Agreement expands access to Labcorp’s diagnostic capabilities and services
BURLINGTON, North Carolina, November 20, 2023 /PRNewswire/ — Labcorp (NYSE: L.H.), a global leader in innovative and comprehensive laboratory services, today announced the completion of previously announced transaction with Legacy Health to acquire certain assets of Legacy’s proximity laboratory business. Labcorp also now manages Legacy’s hospital laboratories under a long-term agreement to provide staffing, leadership, scientific knowledge, analytics, supply chain services and laboratory support.
“This step will benefit the communities of Oregon And Southwest Washington by expanding access to Labcorp’s cutting-edge laboratory services and diagnostic testing,” said Rajat Mehta, Senior Vice President of Labcorp’s Western Division. “Entering this agreement reinforces Labcorp’s commitment to providing access to high-quality testing across the region by building on Legacy Health’s long history of serving communities.”
Legacy is a six-hospital health system including a full-service children’s hospital, a 24-hour behavioral health center and more than 80 primary, specialty and urgent care clinics. Legacy provides comprehensive health services throughout its communities by Portland, Southwest Washington And that of Oregon middle of the Willamette Valley.
Once the full integration is complete, healthcare providers and patients across the region will have more direct and convenient access to Labcorp’s full range of laboratory services. Legacy continues to retain ownership and licensing of its hospital laboratories.
“The providers and patients Legacy serves will benefit from Labcorp’s innovative diagnostic capabilities and comprehensive laboratory services,” said Kecia Kelly, senior vice president and chief nursing officer. “The partnership with Labcorp advances our mission of good health for all. »
Labcorp (NYSE: L.H.) is a global leader in innovative, comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear, confident decisions. We provide information and advance science to improve health and improve lives through our unmatched laboratory diagnostic and drug development capabilities. The company’s more than 60,000 employees serve customers in more than 100 countries, have worked on more than 80% of new drugs approved by the FDA in 2022, and have performed more than 600 million tests for patients around the world . Learn more about us at www.labcorp.com.